Alzheimers Disease Prevention Potential Early studies are investigating GLP-1 receptor agonists like semaglutide for neuroprotective effects, as these drugs appear to reduce amyloid plaque buildup and inflammation in the brain
Productos recomendados Klow Peptide combina BPC-157, TB-500, GHK-Cu y KPV
Nasal Spray: Emerging in 2025 as a potential rapid-delivery research method for localized CNS or vascular endpoints, though formulation standardization remains variable
The SURPASS program, which targeted patients with type 2 diabetes [29, 36,37,38,39,40,41,42], and the SURMOUNT program, which included individuals with obesity but without diabetes [43,44,45], both reported clinically significant reductions in body weight
Its an interesting case for ethical investingmassive market potential but also real questions around safety and long-term impact